期刊
ACTA ENDOCRINOLOGICA-BUCHAREST
卷 6, 期 4, 页码 507-512出版社
EDITURA ACAD ROMANE
DOI: 10.4183/aeb.2010.507
关键词
cancer; FSH receptor; tumor marker; imaging; drug; targeting
Our recent studies, led on 1336 tumor samples coming from 11 types of cancer, published in the New England Journal of Medicine 367:1621-1630 show that the receptor of the follicule-stimulating hormone (FSH receptor) is expressed in a preferential way in the tumor blood vessels. No expression has been detected at the level of the blood vessels in healthy tissues, with the exception of the reproductive organs where it is present in much lower concentrations than in tumors. Being directly accessible to the intravenously delivered agents, the FSH receptor can he used as target for cancer imaging and drug delivery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据